Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.31999DOI Listing

Publication Analysis

Top Keywords

hepatic peliosis
8
controlled red
4
red blood
4
blood cell
4
cell apheresis
4
apheresis pretreatment
4
pretreatment hepatic
4
peliosis resection
4
resection surgery
4
surgery severe
4

Similar Publications

Peliosis hepatis is a rare condition characterized by dilation of the hepatic sinusoids and the presence of multiple blood-filled cystic spaces within the liver parenchyma. It has been associated with a variety of etiologies, including infectious diseases, immunological disorders, malignancy, and certain medications. We report a case of a 24-year-old male who presented with polyarthritis lasting two months.

View Article and Find Full Text PDF

Peliosis hepatis is a rare benign vascular disorder characterized by dilatation of sinusoidal blood-filled spaces within the liver. Peliosis hepatis is most often idiopathic and asymptomatic, it can mimic malignancy and is difficult to diagnose. In this case report, a 41-year-old woman with breast cancer developed multiple hypodensities in the liver during chemotherapy.

View Article and Find Full Text PDF

Vascular Liver Disease: Emerging Concepts in the Sinusoidal Space.

Clin Liver Dis

August 2025

Department of Pathology, New York University Langone Health, 560 First Avenue, New York, NY 10016, USA.

Vascular liver pathology represents a heterogenous group of diseases impacted by the dual blood supply to the liver at each distinct microanatomic site. Portal vein-based disease is well described in association with portal vein thrombosis but may also precede or occur in the absence of thrombosis. Central vein-based disease is also well described in association with right heart failure and Budd Chiari syndrome but may show similar features with sinusoidal obstruction.

View Article and Find Full Text PDF

Liver function in X-linked myotubular myopathy and autosomal dominant centronuclear myopathy: Data of the unite-CNM study.

J Neuromuscul Dis

July 2025

Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.

Background: Centronuclear myopathies represent a subset of debilitating genetic disorders, for which no treatment exists. The Unite-CNM trial (NCT04033159) aimed to assess the effect of an antisense oligonucleotide to reduce mRNA expression in X-linked myotubular myopathy (XLMTM) and autosomal dominant centronuclear myopathy (ADCNM).

Objective: The trial was discontinued due to tolerability concerns (hepatic and hematological).

View Article and Find Full Text PDF